For instructions on how to disable your ad blocker, click here.
Samsung Galaxy Book Flex, one of the first laptops with QLED display, is now on sale in the US. Broaden its trading in the US signifies the company is expanding its production on Laptops.The Galaxy Flex is premium two in 1 Laptop 13.3 and 15.6 inch sizes. It attributes a stylish metal blue design, with an inbuilt fingerprint reader and a slot for the S Pen a small new age stylus which helps you to be more productive.
Share All sharing options Share All sharing options for: This is the last week to preorder Samsung s Galaxy S20 Linkedin Reddit Pocket Flipboard Email Photo by Vjeran Pavic The Verge This story is part of a group of stories called Only the best deals on Verge approved gadgets get the Verge Deals stamp of approval, so if you're looking for a deal on your next gadget or gift from major retailers like Amazon, Walmart, Best Buy, Target, and more, this is the place to be. Vox Media has affiliate partnerships. These do not influence editorial content, though Vox Media may earn commissions for products purchased via affiliate links. For more information, see our ethics policy.
According to a report by SamMobile, the Bixby Voice and Bixby Briefing support on Samsung phones running Android 8 Oreo and Android 7 Nougat will end on January 1, 2020. The Samsung phones that will lose access to these two Bixby features are Samsung Galaxy S9, Galaxy S9 , Galaxy S8, Galaxy S8 , Galaxy S8 Active, Galaxy Note 8, and Galaxy A9 2018. Notably, Samsung Galaxy Note 9 owners who are yet to update from Android 8.1 Oreo will not be impacted by this change. This move is meant to nudge users toward what''s referred to as Bixby 2.0, SamMobile writes. Unveiled with the Galaxy Note 9 last year, it brought a new interface for Bixby Voice in addition to many improvements. The improved Bixby is also better at processing natural language.
However it seems that all those rumors could be false. According to a report from Korea Times (via Photo Rumors), it looks like Samsung has since come forward and denied all those claims. According to a Samsung spokesman, ;It is true that we have not rolled out any new products since February, but we do not have any official plans to withdraw from the camera business. We still have employees working in the division.;The report also suggests that Nikon isnâ€™t interested in acquiring Samsungâ€™s technology. According to their source, this is namely because Nikonâ€™s technology is more advanced. &"I doubt that Nikon is interested in acquiring Samsung&'s camera technologies because the Japanese company already has advanced optical technologies. Should Nikon seek Samsung&'s camera business, it could be for diversification of its product portfolio.&"
Unnamed sources have informed Koreaâ€™s ET News that Samsungâ€™s foundry business has signed on to manufacture AMDâ€™s next graphics chip, code-named Greenland, starting in Q2 2016. The chip will be produced using&second-generation 14nm FinFET LPP processing, making it more power efficient and faster than the current 28nm Fiji GPU on the market. GlobalFoundries, who has licensed Samsung's 14nm FinFET technology,&will produce the Greenland GPU as well.
Samsung BioLogics broke ground on its third production plant in Songdo, Incheon, Monday, drawing closer toward its stated goal of becoming the worldâ€™s No. 1 contract manufacturer of biologic drugs by 2020.The new plant, to be constructed with an investment of 850 billion won ($740 million) will boast a production capacity of 180,000 liters to become the single largest biologics manufacturing facility in the world upon its completion in 2018.Combined with its two existing plants, the new facility will drive Samsungâ€™s total manufacturing capacity to 360,000 liters, leapfrogging current segment leaders Lonza (260,000 liters) and Boehringer Ingelheim (240,000 liters).â€œSamsung BioLogics is looking to become the undisputed No. 1 biologics CMO in terms of manufacturing, revenues and operating profits by the year 2020,â€ Samsung BioLogicsâ€™ chief executive Kim Tae-han told reporters before the groundbreaking ceremony.The firm is looking to rack up 1 trillion won in revenues and 400 billion won in operating profits by 2020, and record 2 trillion won in revenues and 900 billion won in profits by 2025, when all three plants kick into full gear, according to Kim.â€œSamsungâ€™s latest investment will become an innovative model for Koreaâ€™s manufacturing sector and set an important foundation for Koreaâ€™s foray into the upcoming bio-economy age,â€ said President Park Geun-hye in a congratulatory speech.Samsung BioLogics has particularly set its sights on shifting the current production paradigm in the biopharma segment from self-production to outsourcing, as was the case with semiconductors prior to the 1980s.&â€œRight now, contract manufacturing takes up only about 20-30 percent of global biopharma companiesâ€™ total production volume,â€ said the Samsung BioLogics CEO.â€œBy supplying high-quality products at competitive prices, as Samsung did when it first jumped into the semiconductor manufacturing business, we hope that global biopharma companies will partner with CMOs like us over investing huge sums of money into expanding their own facilities,â€ he said.As production demands for biopharmaceuticals will peak in 2020 amid the introduction of new commercial biologic drugs every year, Samsung, boasting record-low operational costs, will be able to retain an upper hand above competing biopharma CMOs, according to Kim. In terms of return on investment, Samsungâ€™s third plant is able to produce biologics at around 43 percent of the cost of its global competitors, according to Samsungâ€™s calculations based on investment to capacity ratios.The Songdo-based company is currently manufacturing commercial biologics developed by its two current partners, Bristol-Myers Squibbs and Roche, at its first plant, which received approval from the U.S. Food and Drug Agency on Dec. 1.In terms of striking further supply contracts with new clients, the company has been â€œsecuring sizeable deals,â€ said Yoon Ho-yeol, vice president of Samsung BioLogicsâ€™ corporate business operations, noting details must remain undisclosed due to corporate compliance rules.As its business takes off, Samsung BioLogics plans to build a fourth and a fifth plant in the coming years, as well as consider the viability of an initial public offering in 2016, said Kim Dong-joong, the companyâ€™s vice president of corporate management. (kes)(+)
Jun was quoted as saying that Xiaomi™s focus is on getting the overall user experience right on the Mi 5, instead of rushing to be the first to boast the Snapdragon 820 chipset, G4Games reports. The company also plans on getting mass production sorted before launching the smartphone, so as to avoid shipping delays later on.What Jun could be hinting at is that Xiaomi is still fine tuning the Mi 5, and at the same time also waiting for Qualcomm to ramp up its Snapdragon 820 chipset production. The production bit is important, since Samsungâ€™s next flagship Galaxy S7 smartphone too is expected to be unveiled in Q1, 2016 boasting Qualcommâ€™s chipset.
Price: The Mate 8 comes in four variants. The base variant (32GB, 3GB of RAM) is priced at the aforementioned CNY 2,999. The 64GB (4GB of RAM) is priced at CNY 3,699 (Rs 38,500 approximately), while the 128GB (4GB of RAM) variant is priced at CNY 4,399 (Rs 45,800 approximately). There is also a Champagne Edition that is priced at CNY 6,888.Samsungâ€™s Galaxy Note 5 is priced at Rs 47,890 (32GB variant), and Rs 54,800 for the 64GB variant. The Nexus 6P, on the other hand, is priced at Rs 39,999 for the 32GB variant, and Rs 42,999 for the 64GB variant.
The Samsung Galaxy S7 is the most anticipated smartphone of early 2016. The Galaxy S7™s specs, price, and release date will be the subject of heavy speculation over the next weeks, especially if the rumors of an early launch turn out to be accurate.If youâ€™re excited about Samsungâ€™s next flagship release, weâ€™re here to bring you all the credible info on the Galaxy S7 in one neat package.